Trial intelligence / Profile preview

Perindopril + indapamide + amlodipine single-pill combination versus perindopril + indapamide in uncontrolled essential hypertension

2012-001658-24Phase 3Completed

Sponsor
Servier
Start
Sep 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of perindopril, indapamide and amlodipine in essential hypertension (2 arms), sponsored by Servier. Primary endpoint: Supine systolic blood pressure. Started Sep 2012; status: completed.

02

Drugs

perindoprilindapamideamlodipine
03

Conditions

essential hypertension

Beyond the preview

Go deeper on 2012-001658-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-001658-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call